Views

Read op-eds and interviews from our staff, allies and partners.

Why Data Matters: HIV in Europe

Last updated:

A new paper published in Eurosurveillance today finds that there has been substantial progress towards achieving the global UNAIDS targets across Europe and Central Asia. Despite this, an estimated 1.2 million people living with HIV still have transmissible levels of the virus because they have been unable to access prevention methods, testing or treatment for HIV. This paper is the first output of nearly two years’ work by NAT as part of the Dublin Declaration monitoring team.

M·A·C COSMETICS – 15 YEARS SUPPORTING NAT

Last updated:

One of our strongest and most longstanding partnerships has been with M·A·C Cosmetics, who as well as stocking our red ribbons on every one of their counters in the UK, have funded much of our work over the last 15 years. To mark 15 years of our partnership, we’re looking back at how M·A·C have led the way in showing how businesses can make a real difference to the lives of people living with HIV/AIDS, tackle stigma and discrimination, and help to end new transmissions.

Glasgow’s major HIV outbreak amongst people who inject drugs shows no sign of slowing

Last updated:

In 2015, an HIV outbreak was detected amongst people who inject drugs (PWIDs) in Glasgow. Three years on the outbreak has still not been controlled, and over 100 PWIDs in Scotland have been diagnosed with HIV. Those diagnosed have complex needs and experience severe social exclusion, with 40% having a history of incarceration and 45% reported ever being homeless.

The People Vs The NHS – are we still fighting for PrEP?

Last updated:

Do we have PrEP in England? Well, yes and no. We have the PrEP Impact trial which currently has 10,000 places available for PrEP in sexual health clinics across the country. The study is being paid for by NHS England, which is a great step forward from where we were two years ago. Back then, the NHS were insisting that they didn’t have the powers to pay for PrEP. NAT had to take the NHS to court to convince them otherwise.